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Background: There is limited data on the resistance mech-
anisms of Diarrhoeagenic Escherichia coli (DEC) from our centre
which prompted us to perform this study to determine the antimi-
crobial resistance pattern.
Methods & Materials: DNA extracted from conﬁrmed DEC
strains (48) isolated between November 2014 to March 2015 from
120 diarrhoeal stool specimens collected from children less than
5 years from were cultured were subjected to PCR for the detec-
tion of antimicrobial resistance genes (gyrA, gyrB, parC, parE, qnrA,
qnrB, qnrS, qnrC, qepA, aac(6′)-Ib, sulI, sulII, sulIII, dhfrI, aac(3)-IV,
aadB, tetA, tetY, tetD, tetE, tetC, tetB, catI, blaCTX, blaTEM blaSHV,
int1, int3, int2 and erm).
Results: All (100%) the strains harboured the quinolone resis-
tance gene gyrB, while, gyrA and parE were present in 93.7% each,
parC in 85.4%, aac(6′)-Ib and qnrS in 41.6% each, qnrB in 34.7%, qnrC
in 31.2%, qepA in 18.7% and qnrA in 12.5%.Geneswhich are responsi-
ble for resistance to aminoglycoside aac(3)-IV (14.5%), aadB (6.2%),
sulfonamides (sulI) (77%), (sulII) (31.2%), (sulIII) (6.2%), trimetho-
prim (dhfrI) (50%) and tetracycline (tetA) (56.25%), (tetY) (20.8%),
(tetD) (18.7%), (tetE) (18.7%), (tetC) (16.6%),(tetB) (8.3%), chloram-
phenicol (catI) (39.58%) and  lactam (blaCTX) (64.5%), (blaTEM)
(20.8%) and (blaSHV) (8.3%)were alsowidely distributed. Integrons
were noted in 70.8% (int1), 33.3% (int3) and 31.2% (int2), while none
harboured the macrolide resistance gene erm.
Conclusion: A diverse pattern was observed with regards to
antimicrobial resistance genes in DEC. This study also illustrates
the importance of integrons in the epidemiology of antibiotic resis-
tance in DEC strains in our setting.
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Background: Theuse of phage therapy as an alternativemethod
of treating infections caused by multidrug-resistant bacteria has
been a controversial issue. The present study sought to determine
safetyand therapeutic efﬁcacyof environmentallyobtainedStaphy-
lococcus aureus lytic phage against multidrug-resistant S.aureus
(MDRSA) in mice.
Methods & Materials: Phages and MDRSA were isolated from
sewage andwastewater collected fromwithin Nairobi County. The
isolated S.aureus bacterium was screened for resistance towards;
Ceftazidime, Oxacillin, Vancomycin, Netilmicin, Gentamicin and
Erythromycin, Trimethroprim-Sulfamethoxazole and Cefuroxime.
Thirty BALB/c mice were randomly assigned into three groups;
the MDRSA infection group (n=20), the phage-infection group
(n=5) and non-infection group (n=5). After 24 or 72hours post-
infection (p.i.) with MDRSA, the infected mice were either treated
with a single dose of clindamycin (8mg/kg/bwt) or 108PFU/ml of
S.aureus phage or a combination (clindamycin and S.aureus phage).
Safety was determined by monitoring animal physical health post-
infection aswell as grosspathology andhistopathology. Bacteremia
was determined daily for 10 days and used to establish therapeutic
efﬁcacy of the phage.
Results: Treatment with phage was efﬁcacious (100%) com-
pared to clindamycin (62.25%) at 24hrs p.i and 87.5% at 72hrs p.i.)
while combination therapy (75% at 24hrs p.i. and 100% at 72hrs
p.i.). Efﬁcacy of the treatment regimenswas dependent on the time
of treatment post infection. The mice infected with MDRSA and
treatedwithphagehadnobacteremiaatday7post-treatment com-
pared to those treated with clindamycin and combination therapy
(P <0.001). There were no tissue abscesses, inﬂammation in the
brain, lungs and liver tissues of phage treated mice compared to
those treated with clindamycin and combination therapy.
Conclusion: The S.aureus phage obtained from sewage and
waste water from within Nairobi County was safe and possessed
therapeutic efﬁcacy against MDRSA bacterium.
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